Self-management interventions for people with chronic obstructive pulmonary disease.
Schrijver J, Lenferink A, Brusse-Keizer M, Zwerink M, van der Valk PD, van der Palen J, Effing TW.
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.
Lange P, Celli B, Agustí A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, Meek P, Owen CA, Petersen H, Pinto-Plata V, Schnohr P, Sood A, Soriano JB, Tesfaigzi Y, Vestbo J.
N Engl J Med. 2015 Jul 9;373(2):111-22. doi: 10.1056/NEJMoa1411532.
Ciclesonide.
Reynolds NA, Scott LJ.
Drugs. 2004;64(5):511-9; discussion 520-1. doi: 10.2165/00003495-200464050-00005.
Associations of pre-COPD indicators with lung function decline and their longitudinal transitions.
Fan J, Cong S, Zhang Y, Jiang X, Wang N, Fang L, Chen Y.
Pulmonology. 2025 Dec 31;31(1):2486881. doi: 10.1080/25310429.2025.2486881. Epub 2025 May 12.
Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one second in a normal population.
Malo JL, Pineau L, Cartier A, Martin RR.
Am Rev Respir Dis. 1983 Jul;128(1):8-11. doi: 10.1164/arrd.1983.128.1.8.
Real-world biologics response and super-response in the International Severe Asthma Registry cohort.
Denton E, Hew M, Peters MJ, Upham JW, Bulathsinhala L, Tran TN, Martin N, Bergeron C, Al-Ahmad M, Altraja A, Larenas-Linnemann D, Murray R, Celis-Preciado CA, Al-Lehebi R, Belhassen M, Bhutani M, Bosnic-Anticevich SZ, Bourdin A, Brusselle GG, Busby J, Canonica GW, Heffler E, Chapman KR, Charriot J, Christoff GC, Chung LP, Cosio BG, Côté A, Costello RW, Cushen B, Fingleton J, Fonseca JA, Gibson PG, Heaney LG, Huang EW, Iwanaga T, Jackson DJ, Koh MS, Lehtimäki L, Máspero J, Mahboub B, Menzies-Gow AN, Mitchell PD, Papadopoulos NG, Papaioannou AI, Perez-de-Llano L, Perng DW, Pfeffer PE, Popov TA, Porsbjerg CM, Rhee CK, Roche N, Sadatsafavi M, Salvi S, Schmid JM, Sheu CC, Sirena C, Torres-Duque CA, Salameh L, Patel PH, Ulrik CS, Wang E, Wechsler ME, Price DB; ISAR LUMINANT Working Group.
Allergy. 2024 Oct;79(10):2700-2716. doi: 10.1111/all.16178. Epub 2024 Jun 22.
Adjunctive N-Acetylcysteine and Lung Function in Pulmonary Tuberculosis.
Wallis RS, Sabi I, Lalashowi J, Bakuli A, Mapamba D, Olomi W, Siyame E, Ngaraguza B, Chimbe O, Charalambous S, Rachow A, Ivanova O, Zurba L, Myombe B, Kunambi R, Hoelscher M, Ntinginya N, Churchyard G.
NEJM Evid. 2024 Sep;3(9):EVIDoa2300332. doi: 10.1056/EVIDoa2300332. Epub 2024 Aug 27.
Exploring dupilumab for asthma: from mechanistic insights to clinical outcomes, safety, and cost-effectiveness.
Ameer OZ, Mansour GK, Al-Amoudi RS, Abu-Owaimer FM.
Front Pharmacol. 2025 Aug 6;16:1631321. doi: 10.3389/fphar.2025.1631321. eCollection 2025.
History of lung volume reduction procedures.
Marruchella A, Faverio P, Bonaiti G, Pesci A.
J Thorac Dis. 2018 Oct;10(Suppl 27):S3326-S3334. doi: 10.21037/jtd.2018.04.165.
Macrolides for chronic asthma.
Kew KM, Undela K, Kotortsi I, Ferrara G.
Cochrane Database Syst Rev. 2015 Sep 15;(9):CD002997. doi: 10.1002/14651858.CD002997.pub4.
